Hims & Hers Health, Inc. reported a strong third quarter in 2024 with revenue of $401.6 million, up 77% year-over-year. The company achieved a net income of $75.6 million and Adjusted EBITDA of $51.1 million. Subscriber base grew to 2.0 million, a 44% increase year-over-year. The company also raised its full year 2024 revenue guidance to a range of $1.460 billion to $1.465 billion and Adjusted EBITDA guidance to a range of $173 million to $178 million.
Revenue increased by 77% year-over-year, reaching $401.6 million in Q3 2024.
Net income was $75.6 million, including a $60.8 million tax benefit.
Adjusted EBITDA was $51.1 million, compared to $12.3 million in the same quarter last year.
The subscriber base grew to 2.0 million, reflecting a 44% year-over-year increase.
Hims & Hers provided revenue and Adjusted EBITDA guidance for Q4 2024 and full year 2024.
Visualization of income flow from segment revenue to net income